Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05923606 · ClinicalTrials.gov registry record · NA

Modulation of Brain Oscillations Underlying Working Memory

A NA study of Working Memory, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT05923606 is a NA study of Working Memory that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 32 participants, below the 62-participant average among 5 other Working Memory trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05923606, a NA study of Working Memory, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

This study will use novel transcranial alternating current stimulation (tACS) protocols and electroencephalography (EEG) to modulate and measure brain oscillations that underlie working memory. tACS is a noninvasive method used to modulate the timing and patterns of brain rhythms via weak electric currents passed through electrodes on the scalp.

Conditions Studied

Interventions

  • DEVICE Active tACS
  • DEVICE Placebo tACS

Study Locations (1)

Massachusetts

  • Martinos Center for Biomedical Imaging - Charlestown

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2024-07-10
Est. Completion 2027-03-31
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT05923606

The ClinicalTrials.gov registry entry for NCT05923606 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 62-participant average among 5 other Working Memory trials with a reported enrollment target (48% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Working Memory appearing as the primary indexed condition, and to 2 interventions - of which Active tACS is the first listed.

NCT05923606 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05923606 about?

NCT05923606 is a clinical study titled "Modulation of Brain Oscillations Underlying Working Memory". This study will use novel transcranial alternating current stimulation (tACS) protocols and electroencephalography (EEG) to modulate and measure brain oscillations that underlie working memory. tACS is a noninvasive method used to modulate the timing and patterns of brain rhythms via weak electric c...

What is the current status of trial NCT05923606?

This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2024-07-10. Estimated completion is 2027-03-31.

What conditions does trial NCT05923606 study?

This clinical trial studies the following conditions: Working Memory.

What interventions are being tested in trial NCT05923606?

The interventions under investigation include: Active tACS (DEVICE), Placebo tACS (DEVICE).

Who is sponsoring clinical trial NCT05923606?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05923606 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Working Memory

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.